Teleflex Incorporated
https://teleflex.com/usa/en/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Teleflex Incorporated
Glaukos Takes Another Hit From CMS; Investors Respond Negatively As Stock Falls
The US Medicare agency's new rule for facility fees brings more bad news for Glaukos; Wells Fargo downgrades company’s stock in response.
Latest Physician Fee Schedule Proposal Could Impact Companies’ Bottom Line
The US Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes new reimbursement levels for multiple medical devices, including the Glaukos iStent.
Teleflex Continues Restructuring By Selling Hudson Respiratory Business To Medline
Medline will pay $286m in cash for Teleflex's oxygen and aerosol therapy, active humidification, and non-invasive ventilation devices as well as incentive spirometers. Those businesses yielded $139m in 2020 revenues, but do not fit into Teleflex's plan for the future.
Finance Watch: Biotech Venture Capital Had Its Biggest Quarter Ever
Private Company Edition: VC mega-rounds boosted the Q1 2021 total. Also, new funds from Versant, The Column Group and Rapha Capital keep cash flowing into biopharma; up to $525m is invested in Exscientia; and Arch Oncology and Boundless Bio raised $105m each, while Forge brought in $120m.
Company Information
- Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
- Infusion Therapy Equipment and Supplies
- Surgical Equipment & Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
-
- Arrow International
- Eon Surgical Ltd
- Hotspur Technologies
- Essential Medical, Inc.
- Hudson Respiratory Care, Inc.
- LMA International N.V.
- NeoTract, Inc.
- Nostix, LLC
- Pyng Medical Corporation
- Semprus BioSciences
- Ultimate Medical
- Vascular Solutions
- Vasonova Inc.
- Vidacare Corporation